Magnesium Isoglycyrrhizinate Hydrate

异甘草酸镁

Report date: 2023/03/15 17:49:06

Base Information

Drug NameMagnesium Isoglycyrrhizinate Hydrate
Drug Alias Name异甘草酸镁水合物Gan Mei天晴甘美NSC-167409NSC-234419
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsEczemaHepatitis, ChronicChemical and Drug Induced Liver Injury
Global Approved IndicationsHepatitis, Chronic
Approved Indications in ChinaHepatitis, Chronic
Original Approved Country/TerritoryMainland China
Original Approved Date2005/09/26
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis, Chronic
Inactive IndicationsEczemaChemical and Drug Induced Liver Injury

Other Information

ATC CodeA05
Related LinksN/A